New treatment recommended for children with brain tumours

The European Medicines Agency has recommended conditional approval of a new targeted treatment for children with the brain tumour pediatric low-grade glioma.

Multicancer test failed to meet its goal – shares plunged

A blood test designed to detect multiple types of cancer failed to meet its primary endpoint in a large UK study. The company behind the test saw its market value cut in half.

Meet ZEISS at ELRIG Advances in Cell-based Screening 2026

Reserve your spot now.

Cinclus welcomes FDA announcement on single‑study requirement

Swedish Cinclus Pharma welcomes the signals from the United States that a single pivotal study, rather than two, may be sufficient when applying for market approval.

Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

New moves around Nykode's management – withdrawal of resignations

Norwegian Nykode Therapeutics is reinstating members of the management team who previously announced their resignations.

ISO 13485 Standard Internal Auditing Course

Do you work with medical devices and quality management? Strengthen your expertise with our ISO 13485 Standard Internal Auditing Training — designed to give you...

Painkiller cuts recurrence risk by more than 50% – national guidelines updated

Sweden’s national guidelines for colon and rectal cancer have been updated — just nine months after the previous revision. The move follows new Swedish research...

Mercodia AB

Asgard teaches tumours to self‑destruct – moving closer to clinical trials

Swedish biotech Asgard Therapeutics not only has an evocative name, but also a remarkably exciting approach to cancer treatment: getting tumour cells to reprogr...

Clinical evaluation of class I medical devices

The Swedish Medtech Regulatory Summit is just around the corner — taking place on March 12th at Hilton Slussen in Stockholm. We’re proud to share that our Senio...

National cord blood bank resumes collection

The collection of umbilical cord blood is now resuming during planned caesarean sections at Östra Hospital in Gothenburg. The blood remaining in the placenta an...

Swedish drug development projects in Phase III – studies to keep an eye on

Developing new medicines is, as we know, a lengthy and uncertain process, and only a fraction of all projects ever reach late clinical phase. But it does happen...

Internal audits based on ISO 13485 for medtech organizations

Are you ready to turn your internal audits into real improvements? Internal auditing isn’t just about compliance—it’s a strategic tool for driving development a...

Quretech granted a European patent for a new type of antibiotic

The European patent provides protection until 2041. Previously, the patent was granted in China, and the application is currently under review in the USA, India, and Japan.

Are you prepared for the updated ISO 10993 1:2025?

The latest edition of ISO 10993-1 reinforces the integration of biological evaluation with risk management, introduces updated approaches to exposure assessment...

The Versatile Solution for Quality Management and Data Analysis

Join our ZEISS PiWeb webinar on March 26.

From pharmacist to life science podcaster – Magnus Lejelöv uses his voice as a tool

Magnus Lejelöv has more than 20 years of experience in the pharmaceutical industry and has conducted nearly two hundred interviews with healthcare professionals...

Cell-free cartilage from Lund could pave the way for new bone transplants

Researchers at Lund University have developed a new method for repairing large bone defects, based on laboratory-engineered, cell-free cartilage grafts. The tec...

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

International medical graduates leave Sweden in high numbers

Three years after completing their studies, 46 percent of international doctoral students who graduated in the medical field had left the country. This is shown...

The investor: “The major common diseases are hot again”

She has previously been voted Investor of the Year and will now be moderating The Future of Swedish & Danish Life Science congress. We check the temperature of ...

Lundbeck appoints Chief AI Officer

Danish pharmaceutical company Lundbeck has appointed Markus Kede as Chief AI Officer. He will join the Executive Leadership Team and report to President and CEO Charl van Zyl.

Finland leads the way in the hunt for international top researchers

Several Nordic initiatives are currently under way to recruit international top researchers. Finland is making its largest national investment ever in attractin...